| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |